Pharming Group NV operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pharming Group with three other
miscellaneous service companies in Europe:
sales of 99.93 million Norwegian Kroner [US$11.71 million]
(11.20 million Euro [US$11.87 million]
of which 100%
was Royalty Income), and
Circassia Pharmaceuticals PLC
based in the United Kingdom
(£10.80 million [US$13.01 million]
of which 95%
During the year ended December of 2015, sales at
Pharming Group were 10.83 million Euro (US$11.48 million).
decrease of 48.9%
versus 2014, when the company's sales were 21.19 million Euro.